P1695: REAL-WORLD SURVIVAL, HEALTHCARE RESOURCE UTILIZATION, AND COSTS AMONG U.S. ELDERLY PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) TREATED WITH R-GEMOX IN THE RELAPSED/REFRACTORY SETTING

• Mahek Garg,
• Justin Puckett,
• Sachin Kamal-Bahl,
• Monika Raut,
• Katherine Ryland,
• Samhita Chakraborty,
• Jalpa Doshi,
• Scott Huntington

Affiliations

Mahek Garg

1 Merck & Co., Inc.

Justin Puckett

2 COVIA Health Solutions

Sachin Kamal-Bahl

2 COVIA Health Solutions

Monika Raut

1 Merck & Co., Inc.

Katherine Ryland

1 Merck & Co., Inc.

Samhita Chakraborty

1 Merck & Co., Inc.

Jalpa Doshi

3 Perelman School of Medicine at the University of Pennsylvania

Scott Huntington

4 Yale University School of Medicine